Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Switzerland
/
Pharmaceuticals & Biotech
Create a narrative
Galderma Group Community
SWX:GALD Community
1
Narratives
written by author
0
Comments
on narratives written by author
14
Fair Values set
on narratives written by author
Create a narrative
Community Investing Ideas
Galderma Group
Popular
Undervalued
Overvalued
Galderma Group
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Global Aesthetics And Aging Trends Will Drive Expansion
Key Takeaways Accelerated growth and profitability are driven by innovative, premium products, digital engagement, and expanding presence in emerging markets. Strategic R&D investments and partnerships enhance Galderma's ability to capture rising demand for advanced dermatological and aesthetic solutions.
View narrative
CHF 136.99
FV
4.8% undervalued
intrinsic discount
14.53%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
about 7 hours ago
author updated this narrative
Your Valuation for
GALD
GALD
Galderma Group
Your Fair Value
CHF
Current Price
CHF 130.40
34.2% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-90m
8b
2015
2018
2021
2024
2025
2027
2030
Revenue US$8.5b
Earnings US$682.0m
Advanced
Set Fair Value